GBA Presents: House of Gummy-!

Discussion in 'Stocks' started by stonedinvestor, May 13, 2023.




  1. Sold yesterday of course before earnings. That was my second round I have really done well with this RIVN I like the the name.
     
    #7721     Oct 5, 2023
    TrailerParkTed likes this.
  2. vanzandt

    vanzandt

    Oct $26 calls
    Bid----> $.08

    Ted....
    Is it bad taste to wear the same suit to the Option King's funeral that I wore to the Lizard King's?
    I'm having an $11,500 day and I really don't feel like going to Macys. Does grubhub deliver tailors?
     
    #7722     Oct 5, 2023
  3. vanzandt

    vanzandt

    Este Lauder---> $141.50 :thumbsup:
     
    #7723     Oct 5, 2023
  4. After my work out lets talk META.-

    I see some ways of using options on this name.


    NOV 17 Call 320.00
    $11.50<------- way more that I like
    -2.60
    -18.44% <---- slight discount.
     
    #7724     Oct 5, 2023
    vanzandt likes this.
  5. vanzandt

    vanzandt

    Actually, that might not be a bad call.
     
    #7725     Oct 5, 2023
  6. LONGSHOT-

    -> CLNN .51C

    Clene Inc. (CLNN) Taking a chance here-- was .66 today on large contract
    NasdaqCM - NasdaqCM Real Time Price.
    0.5210+0.0269(+5.4442%)
    As of 10:12AM EDT. Market open.






    [​IMG]
    Clene Inc.
    Funding to Support Research and Expanded Access of Investigational Drug in ALS

    SALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (NINDS), a division of the National Institutes of Health (NIH), to support an Expanded Access Protocol (EAP) for the Company’s investigational drug, CNM-Au8®, in amyotrophic lateral sclerosis (ALS). An EAP is also referred to as Compassionate Use and is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S. Food and Drug Administration (FDA). In addition to this new EAP, Clene will continue to conduct its currently ongoing ALS EAP programs that have enrolled more than 200 participants since 2019.
     
    #7726     Oct 5, 2023


  7. Vz META being talked about alot now. I think earn are going to be very good.
     
    #7727     Oct 5, 2023
  8. Van take 1/2 position here--

    Elastic N.V. (ESTC)
    NYSE - Nasdaq Real Time Price.
    75.10-0.85(-1.13%)
    As of 10:19AM EDT.
    Yes it's broken trend or whatever but it is stil above 50 and 200 day

    Use $69 area as a mental stop.

    Talk to You at noon!
     
    #7728     Oct 5, 2023
  9. 30 LW $100 puts, $1.8-2.20 ave.
     
    #7729     Oct 5, 2023
    vanzandt likes this.
  10. $3.1 x 3.40.
     
    #7730     Oct 5, 2023